Genetic and Immunological Determinants of Atopic Dermatitis: A Systematic Review

Authors

  • Maria Zofia Lisiecka Department of Allergology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland

DOI:

https://doi.org/10.6000/1929-4247.2025.14.04.4

Keywords:

Skin inflammation, epidermal barrier, hypersensitivity, keratinocytes, skin microbiome

Abstract

Purpose: The present work aimed to study the role of genetic and immunological factors in the development of atopic dermatitis (AD).

Material and Methods: A thorough systematic search of relevant information on AD presented in the PubMed, ResearchGate, Scopus, Web of Science, and Google Scholar databases for 2010-2023 was carried out. The total number of studies included was 50, with a primary focus on genetic association studies, epigenetic studies, and microbiome studies.

Results: The etiopathogenetic mechanisms of the pathogenesis remain under active investigation. It has been determined that the primary factors in the occurrence of AD pathology are the interaction between genetic abnormalities and environmental factors, including climatic factors (temperature, humidity), geographic location (urban vs. rural), air pollution (e.g., particulate matter, ozone), dietary influences (e.g., fat intake, allergens), and exposure to microbes (e.g., pets, infections). An imbalance of the normal intestinal microbiota is a significant predisposing factor. The pathogenetic basis of the disease is an inflammatory process with activation of the T-cell immune response and dysfunction of the genes encoding filaggrin, transglutaminase, and keratin. These disorders lead to increased permeability of the skin barrier and unhindered penetration of allergens. AD is a heterogeneous, multifaceted condition characterised by various endotypes, phenotypes, and clinical subtypes. It frequently commences in early childhood, during the maturation of the immune system and skin barrier. Typical symptoms encompass xerosis, erythema, and pruritus, with affected children exhibiting increased sensitivity to benign irritants, indicative of early immunological dysregulation.

Conclusion: AD substantially lowers quality of life and presents mental health risks, especially in young patients. The early onset underscores the necessity for swift action to facilitate immunological development and protect child health.

References

Durango KP, Fuxench ZCC. Global burden of atopic dermatitis: Examining disease prevalence across pediatric and adult populations worldwide. Dermatol Clin 2024; 42: 519-525. DOI: https://doi.org/10.1016/j.det.2024.05.004

Bylund S, von Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: A systematic review. Acta Derm Venereol 2020; 100(12): 320-329. DOI: https://doi.org/10.2340/00015555-3510

Eczema Stats. 2023. https://nationaleczema.org/research/ eczema-facts/

Nedoszytko B, Reszka E, Gutowska-Owsiak D, Trzeciak M, Lange M, Jarczak J, et al. Genetic and epigenetic aspects of atopic dermatitis. Int J Mol Sci 2020; 21(18): 6484. DOI: https://doi.org/10.3390/ijms21186484

Mu Z, Zhang J. The role of genetics, the environment, and epigenetics in atopic dermatitis. In: Chang C, Lu Q, editors. Epigenetics in allergy and autoimmunity. Singapore: Springer 2020; pp. 107-140. DOI: https://doi.org/10.1007/978-981-15-3449-2_4

Ryguła I, Pikiewicz W, Grabarek BO, Wójcik M, Kaminiów K. The role of the gut microbiome and microbial dysbiosis in common skin diseases. Int J Mol Sci 2024; 25(4): 1984. DOI: https://doi.org/10.3390/ijms25041984

Nakashima C, Yanagihara S, Otsuka A. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors. Allergol Int 2022; 71(1): 40-46. DOI: https://doi.org/10.1016/j.alit.2021.10.004

Eichenfield L, Stripling S, Fung S, Cha A, O’Brien A, Schachner LA. Recent developments and advances in atopic dermatitis: A focus on epidemiology, pathophysiology, and treatment in the pediatric setting. Pediatr Drugs 2022; 24(4): 293-305. DOI: https://doi.org/10.1007/s40272-022-00499-x

Napolitano M, Fabbrocini G, Martora F, Genco L, Noto M, Patruno C. Children's atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implications. Dermatol Ther 2022; 35(12): e15901. DOI: https://doi.org/10.1111/dth.15901

Laska L, Tota M, Łacwik J, Sędek Ł, Gomułka K. IL-22 in atopic dermatitis. Cells 2024; 13(16): 1398. DOI: https://doi.org/10.3390/cells13161398

Chopra R, Vakharia P, Sacotte R, Patel N, Immaneni S, White T, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, atopic dermatitis severity index, and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol 2017; 177(5): 1316-1321. DOI: https://doi.org/10.1111/bjd.15641

Kuo HC, Chu CH, Su YJ, Lee CH. Atopic dermatitis in Taiwanese children: The laboratory values that correlate best to the SCORAD Index are total IgE and positive cheddar cheese IgE. Medicine 2020; 99(30): e21255. DOI: https://doi.org/10.1097/MD.0000000000021255

Park CO, Kim SM, Lee KH, Bieber T. Biomarkers for phenotype-endotype relationship in atopic dermatitis: A critical review. eBioMedicine 2024; 103: 105121. DOI: https://doi.org/10.1016/j.ebiom.2024.105121

Facheris P, Jeffery J, del Duca E, Guttman-Yassky E. The translational revolution in atopic dermatitis: The paradigm shift from pathogenesis to treatment. Cell Mol Immunol 2023; 20(5): 448-474. DOI: https://doi.org/10.1038/s41423-023-00992-4

Schmuth M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, Blunder S, Trafoier T, et al. Skin barrier in atopic dermatitis. J Invest Dermatol 2024; 144(5): 989-1000. DOI: https://doi.org/10.1016/j.jid.2024.03.006

De Boer FL, van der Molen HF, Kezic S. Epidermal biomarkers of the skin barrier in atopic and contact dermatitis. Contact Dermatitis 2023; 89(4): 221-229. DOI: https://doi.org/10.1111/cod.14391

Boothe WD, Tarbox JA, Tarbox MB. Atopic dermatitis: Pathophysiology. In: Feldman SR, Strowd LC, Lovell KK, editors. Management of Atopic Dermatitis. Cham: Springer 2024; p. 21-35. DOI: https://doi.org/10.1007/978-3-031-54513-9_3

Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, et al. The Epithelial Immune Microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol 2018; 19(12): 1286-1298. DOI: https://doi.org/10.1038/s41590-018-0256-2

Hartmane I, Mikažans I, Ivdra I, Derveniece A, Ančupane I. Experience of phototherapy in dermatological praxis in complex therapy of psoriasis patients. Proc Latv Acad Sci B Nat Exact Appl Sci 2016; 70(1): 7-12. DOI: https://doi.org/10.1515/prolas-2016-0002

Hartmane I, Ivdra I, Mikazans I, Bondare-Ansberga V. Immunopathogenic treatment options for psoriasis patients under a restrictive reimbursement environment. Proc Latv Acad Sci B Nat Exact Appl Sci 2021; 75(3): 158-166. DOI: https://doi.org/10.2478/prolas-2021-0025

Ahlström MG, Bjerre RD, Ahlström MG, Skov L, Johansen JD. Stratum corneum lipids in non-lesional atopic and healthy skin following moisturizer application: A randomized clinical experiment. Life 2024; 14(3): 345. DOI: https://doi.org/10.3390/life14030345

Emmert H, Baurecht H, Thielking F, Stölzl D, Rodriguez E, Harder I, et al. Stratum corneum lipidomics analysis reveals altered ceramide profile in atopic dermatitis patients across body sites with correlated changes in skin microbiome. Exp Dermatol 2021; 30: 1398-1408. DOI: https://doi.org/10.1111/exd.14185

Atopic dermatitis in children. 2025. https://www.stanford-childrens.org/en/topic/default?id=atopic-dermatitis-in-children-90-P01675

Fishbein AB, Cheng BT, Tilley CC, Begolka WS, Carle AC, Forrest CB, et al. Sleep disturbance in school-aged children with atopic dermatitis: Prevalence and severity in a cross-sectional sample. J Allergy Clin Immunol Pract 2021; 9(8): 3120-3129e.3. DOI: https://doi.org/10.1016/j.jaip.2021.04.064

Davydenko KI, Maltsev DV, Natrus LV. Indicators of immune status in women with different recurrence rates of nonspecific inflammatory diseases of the genital organs. Zaporozhye Med J 2023; 25(3): 248-254. DOI: https://doi.org/10.14739/2310-1210.2023.3.269374

Hartmane I. Study of genetic mutations and their association with the development of atopic dermatitis and other skin diseases. Plast Aesthet Nurs 2024; 44(3): 200-209. DOI: https://doi.org/10.1097/PSN.0000000000000564

Bjerre RD, Holm JB, Palleja A, Sølberg J, Skov L, Johansen JD. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungi, and viruses. BMC Microbiol 2021; 21(1): 256. DOI: https://doi.org/10.1186/s12866-021-02302-2

Sivori F, Cavallo I, Truglio M, de Maio F, Sanguinetti M, Fabrizio G, et al. Staphylococcus aureus colonising the skin microbiota of adults with severe atopic dermatitis exhibits genomic diversity and convergence in biofilm traits. Biofilm 2024; 8: 100222. DOI: https://doi.org/10.1016/j.bioflm.2024.100222

di Domenico EG, Cavallo I, Capitanio B, Ascenzioni F, Pimpinelli F, Morrone A, et al. Staphylococcus aureus and the cutaneous microbiota biofilms in the pathogenesis of atopic dermatitis. Microorganisms 2019; 7(9): 301. DOI: https://doi.org/10.3390/microorganisms7090301

Cunico D, Giannì G, Scavone S, Buono EV, Caffarelli C. The relationship between asthma and food allergies in children. Children 2024; 11(11): 1295. DOI: https://doi.org/10.3390/children11111295

Navruzov SN, Polatova DS, Geldieva MS, Nurieva EI. Possibilities of study of the main cytokines of the immune system in patients with osteogenic sarcoma. Vopr Onkol 2013; 59(5): 599-602.

Bratu D, Boda D, Caruntu C. Genomic, epigenomic, transcriptomic, proteomic and metabolomic approaches in atopic dermatitis. Curr Issues Mol Biol 2023; 45(6): 5215-5231. DOI: https://doi.org/10.3390/cimb45060331

Nattkemper LA, Tey HL, Valdes-Rodriguez R, Lee H, Mollanazar NK, Albornoz C, et al. The genetics of chronic itch: Gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Invest Dermatol 2018; 138(6): 1311-1317. DOI: https://doi.org/10.1016/j.jid.2017.12.029

Sun M, Chen Z, Ding H, Feng J. Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets. Acta Pharmacol Sin 2024. DOI: https://doi.org/10.1038/s41401-024-01400-x

Meng J, Li Y, Fischer MJM, Steinhoff M, Chen W, Wang J. 2021. Th2 modulation of transient receptor potential channels: An unmet therapeutic intervention for atopic dermatitis. Front Immunol 2021; 12: 696784. DOI: https://doi.org/10.3389/fimmu.2021.696784

Sugaya, M. The role of Th17-related cytokines in atopic dermatitis. Int J Mol Sci 2020; 21: 1314. DOI: https://doi.org/10.3390/ijms21041314

Bitton A, Avlas S, Reichman H, Itan M, Karo-Atar D, Azouz NP, et al. A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis. Sci Immunol 2020; 5: eaaw2938. DOI: https://doi.org/10.1126/sciimmunol.aaw2938

Beck LA, Cork MJ, Amagai M, de Benedetto A, Kabashima K, Hamilton JD, et al. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov 2022; 2(5): 100131. DOI: https://doi.org/10.1016/j.xjidi.2022.100131

Çetinarslan T, Kümper L, Fölster-Holst R. The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis- an update. Front Mol Biosci 2023; 10: 1159404. DOI: https://doi.org/10.3389/fmolb.2023.1159404

Guo Z, Yang Y, Liao Y, Shi Y, Zhang LJ. Emerging roles of adipose tissue in the pathogenesis of psoriasis and atopic dermatitis in obesity. JID Innov 2021; 2(1): 100064. DOI: https://doi.org/10.1016/j.xjidi.2021.100064

Wang Z, Liang X, Li X, Zhou Z, Zhang Z, Zhao J, et al. Global, regional, and national burdens of atopic dermatitis under 14: A trend analysis and future prediction based on the global burden of disease study 2019. Arch Dermatol Res 2024; 316(7): 463. DOI: https://doi.org/10.1007/s00403-024-03195-7

Kashaf SS, Harkins CP, Deming C, Joglekar P, Conlan S, Holmes CJ, et al. Staphylococcal diversity in atopic dermatitis from an individual to a global scale. Cell Host Microbe 2023; 31(4): 578-592. DOI: https://doi.org/10.1016/j.chom.2023.03.010

Wang Z, Hülpüsch C, Foesel B, Traidl-Hoffmann C, Reiger M, Schloter M. Genomic and functional divergence of Staphylococcus aureus strains from atopic dermatitis patients and healthy individuals: Insights from global and local scales. Microbiol Spectr 2024; 12(10): e0057124. DOI: https://doi.org/10.1128/spectrum.00571-24

Zhang R, Wang J. Breast milk components modulate gut microbiota to increase susceptibility to atopic dermatitis in early life. Gut 2025; 74: 3-5. DOI: https://doi.org/10.1136/gutjnl-2024-333235

Zhong LS, Chen XY, Xiao J. Associations between interleukin-13, interleukin-4, and their receptor gene polymorphisms and susceptibility to atopic dermatitis in a Chinese Han population. Indian J Dermatol Venereol Leprol 2024; 90(6): 769-776. DOI: https://doi.org/10.25259/IJDVL_470_2023

Lee JS, Kim SR, Kim DH, Cho SI, Lee DH. Early-life diet and persistent atopic dermatitis: A nationwide cohort study. Allergy 2025; 80: 1455-1459. DOI: https://doi.org/10.1111/all.16469

Yang XP, Liu YY, Zhang CY, Huang KK, Han SS, Liang BY, et al. An observational study: Association between atopic dermatitis and bacterial colony of the skin based on 16S rRNA gene sequencing. Clin Cosmet Investig Dermatol 2024; 17: 1649-1659. DOI: https://doi.org/10.2147/CCID.S464431

Yang P, Li Y, Li T, Yuan L, Wang S. Screening differentially expressed genes and the pathogenesis in atopic dermatitis using bioinformatics. Cell Mol Biol 2023; 69(15): 73-78. DOI: https://doi.org/10.14715/cmb/2023.69.15.12

Yosipovitch G, Berger T, Fassett MS. Neuroimmune interactions in chronic itch of atopic dermatitis. J Eur Acad Dermatol Venereol 2020; 34(2): 239-250. DOI: https://doi.org/10.1111/jdv.15973

Chaudhary PP, Myles IA, Zeldin J, Dabdoub S, Deopujari V, Baveja R, et al. Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis. Allergy 2023; 78: 2724-2731. DOI: https://doi.org/10.1111/all.15806

Godlewska U, Brzoza P, Kwiecień K, Kwitniewski M, Cichy J. Metagenomic studies in inflammatory skin diseases. Curr Microbiol 2020; 77: 3201-3212. DOI: https://doi.org/10.1007/s00284-020-02163-4

Starr NML, Al-Rayyan N, Smith, JM, Sandstrom S, Swaney MH, Salamzade R, et al. Combined metagenomic- and culture-based approaches to investigate bacterial strain-level associations with medication-controlled mild-to-moderate atopic dermatitis. J Allergy Clin Immunol Glob 2024; 3(3): 100259. DOI: https://doi.org/10.1016/j.jacig.2024.100259

Dahal A, Chang WC, Johansson E, Grashel B, Morgan D, Williams L, et al. Skin Staphylococcus aureus detection and relationship to atopic dermatitis outcomes using culture and metagenomic sequencing. Sci Rep 2025; 15: 17606. DOI: https://doi.org/10.1038/s41598-025-99463-1

Hartmane I, Mikaþâns I, Ivdra I, Bondare-Ansberga V, Teterina I, Bataraga E. Retrospective cohort study comparing efficacy and safety of pharmacological intervention and phototherapy in moderate to severe psoriasis patients in a real-world setting. Proc Latv Acad Sci B Nat Exact Appl Sci 2024; 78(2): 141-146. DOI: https://doi.org/10.2478/prolas-2024-0021

Xue Y, Zhang L, Chen Y, Wang H, Xie J. Gut microbiota and atopic dermatitis: A two-sample mendelian randomisation study. Front Med 2023; 10: 1174331. DOI: https://doi.org/10.3389/fmed.2023.1174331

Boutsikou T, Sekkidou M, Karaglani E, Krepi A, Moschonis G, Nicolaou N, et al. The impact of infant feeding regimen on cow's milk protein allergy, atopic dermatitis, and growth in high-risk infants during the first 6 months of life: The allergy reduction trial. Nutrients 2023; 15(11): 2622. DOI: https://doi.org/10.3390/nu15112622

Mahmud R, Akter S, Tamanna SK, Mazumder L, Esti IZ, Banerjee S, et al. Impact of gut microbiome on skin health: Gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes 2022; 14(1): 2096995. DOI: https://doi.org/10.1080/19490976.2022.2096995

Januszewski J, Forma A, Zembala J, Flieger M, Tyczyńska M, Dring JC, et al. Nutritional supplements for skin health: a review of what should be chosen and why. Medicina 2023; 60(1): 68. DOI: https://doi.org/10.3390/medicina60010068

Chernikova D, Yuan I, Shaker M. Prevention of allergy with diverse and healthy microbiota: An update. Curr Opin Pediatr 2019; 31(3): 418-425. DOI: https://doi.org/10.1097/MOP.0000000000000766

Ai S, Liu L, Xue Y., Cheng X, Li M, Deng Q. Prenatal exposure to air pollutants associated with allergic diseases in children: Which pollutant, when exposure, and what disease? A systematic review and meta-analysis. Clinic Rev Allerg Immunol 2024; 66: 149-163. DOI: https://doi.org/10.1007/s12016-024-08987-3

Guo M, Fang Y, Peng M, He C, Chen J, Sun B, Liu C, Zhou Y, Zhang H, Zhao K. Prenatal exposure to polycyclic aromatic hydrocarbons and phthalate acid esters and gestational diabetes mellitus: A prospective cohort study. Int J Hyg Environ Health 2024; 261: 114419. DOI: https://doi.org/10.1016/j.ijheh.2024.114419

Hanifin JM, Baghoomian W, Grinich E, Leshem YA, Jacobson M, Simpson EL. The Eczema Area and Severity Index – A Practical Guide. Dermatitis 2022; 33(3): 187-192. DOI: https://doi.org/10.1097/DER.0000000000000895

Melli LCFL, do Carmo-Rodrigues MS, Araújo-Filho HB, Mello CS, Tahan S, Pignatari ACC, et al. Gut microbiota of children with atopic dermatitis: A controlled study in the metropolitan region of São Paulo, Brazil. Allergol Immunopathol 2020; 48(2): 107-115. DOI: https://doi.org/10.1016/j.aller.2019.08.004

Fujii M. Current understanding of pathophysiological mechanisms of atopic dermatitis: Interactions among skin barrier dysfunction, immune abnormalities, and pruritus. Biol Pharm Bull 2020; 43(1): 12-19. DOI: https://doi.org/10.1248/bpb.b19-00088

Schapovalova O, Gorlova A, de Munter J, Sheveleva E, Eropkin M, Gorbunov N, et al. Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice. Front Med 2022; 9: 952977. DOI: https://doi.org/10.3389/fmed.2022.952977

Yaremchuk NI, Oshurko AP, Oliinyk IY. Age assessment of the dynamics of morphological rearrangement of bone tissue of the articular processes of the human lower jaw, depending on the loss of the masticatory teeth. Pol Merkur Lekarski 2023; 51(2): 120-127. DOI: https://doi.org/10.36740/Merkur202302103

Postic SD. Specific occlusal scheme for partially edentulous patients with TMD signs-preliminary report. J Stomatol Oral Maxillofac Surg 2018; 119(4): 337-347. DOI: https://doi.org/10.1016/j.jormas.2018.04.009

Ushenko YuA, Dubolazov AV, Karachevtcev AO, Zabolotna NI. A fractal and statistical analysis of Mueller-matrix images of phase inhomogeneous layers. Proc SPIE 2011; 8134: 81340P. DOI: https://doi.org/10.1117/12.891812

Nowak R, Ali MJ. Endoscopic coronary catheter dacryoplasty for failed DCR in Wegener’s granulomatosis. Ocul Immunol Inflamm 2023; 31(3): 599-600. DOI: https://doi.org/10.1080/09273948.2022.2032200

Nowak R. Management of inferior dislocation of a StopLoss Jones tube after conjunctivodacryocystorhinostomy. BMJ Case Rep 2020; 13(11): e236003. DOI: https://doi.org/10.1136/bcr-2020-236003

Kozlovska TI, Kolisnik PF, Zlepko SM, Titova NV, Pavlov VS, Wójcik W, et al. Physical-mathematical model of optical radiation interaction with biological tissues. Proc SPIE 2017; 10445: 104453G. DOI: https://doi.org/10.1117/12.2280928

Nowak R. Ocular siderosis resulting from a retained intralenticular metallic foreign body. BMJ Case Rep 2020; 13(6): e235228. DOI: https://doi.org/10.1136/bcr-2020-235228

Nowak R, Rekas M, Ali MJ. Long-term quality of life in patients following minimally invasive conjunctivodacryocys-torhinostomy with stop-loss Jones tube. Ophthalmic Plast Reconstr Surg 2022; 38(2): 170-175. DOI: https://doi.org/10.1097/IOP.0000000000002017

Ushenko YA, Dubolazov AV, Angelsky AP, Sidor MI, Bodnar GB, Koval G, et al. Laser polarization fluorescence of the networks of optically anisotropic biological crystals. Proc SPIE 2013; 8698: 869809. DOI: https://doi.org/10.1117/12.2019350

Dmytriiev D, Dobrovanov, O. Post-COVID pain syndrome. Anaesth Pain Intensive Care 2021; 25(4): 505-512. DOI: https://doi.org/10.35975/apic.v25i4.1582

Aktaeva LM, Mirzakhmetova DD, Padaiga Z. Extragenital pathologies of pregnant women in the southern regions of the Republic of Kazakhstan. Sys Rev Pharm 2020; 11(4): 405-412. DOI: https://doi.org/10.31838/srp.2020.4.61

Diaferio L, Parisi GF, Brindisi G, Indolfi C, Marchese G, Ghiglioni DG, et al. Cross-sectional survey on impact of paediatric COVID-19 among Italian paediatricians: Report from the SIAIP rhino-sinusitis and conjunctivitis committee. Ital J Pediatr 2020; 46(1): 146. DOI: https://doi.org/10.1186/s13052-020-00906-4

Trikamjee T, Comberiati P, D'Auria E, Peroni D, Zuccotti GV. Nutritional Factors in the Prevention of Atopic Dermatitis in Children. Front Pediatr 2021; 8: 577413. DOI: https://doi.org/10.3389/fped.2020.577413

Niseteo T, Hojsak I, Ožanić Bulić S, Pustišek N. Effect of omega-3 polyunsaturated fatty acid supplementation on clinical outcome of atopic dermatitis in children. Nutrients 2024; 16(17): 2829. DOI: https://doi.org/10.3390/nu16172829

Bellinato F, Gisondi P. The role of vitamin D in atopic dermatitis. Vitamin D – Updates 2021; 4(1): 4-7.

World Health Organization. 2023. Exclusive breastfeeding for optimal growth, development, and health of infants. https://www.who.int/tools/elena/interventions/exclusive-breastfeeding

Bonamonte D, Filoni A, Vestita M, Romita P, Foti C, Angelini G. The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis. Biomed Res Int 2019; 2450605. DOI: https://doi.org/10.1155/2019/2450605

Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls I. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol 2010; 162(5): 964-973. DOI: https://doi.org/10.1111/j.1365-2133.2010.09689.x

Shinohara M, Matsumoto K. Fetal Tobacco smoke exposure in the third trimester of pregnancy is associated with atopic eczema/dermatitis syndrome in infancy. Pediatr Allergy Immunol Pulmonol 2017; 30(3): 155-162. DOI: https://doi.org/10.1089/ped.2017.0758

Kim YM, Kim J, Jung K, Eo S, Ahn K. The effects of particulate matter on atopic dermatitis symptoms are influenced by weather type: Application of Spatial Synoptic Classification (SSC). Int J Hyg Environ Health 2018; 221(5): 823-829. DOI: https://doi.org/10.1016/j.ijheh.2018.05.006

Lee JY, Lamichhane DK, Lee M, Ye S, Kwon JH, Park M-S, et al. Preventive effect of residential green space on infantile atopic dermatitis associated with prenatal air pollution exposure. Int J Environ Res Public Health 2018; 15(1): 102. DOI: https://doi.org/10.3390/ijerph15010102

Goh MS, Yun JS, Su JC. Management of atopic dermatitis: A narrative review. Med J Aust 2022; 216(11): 587-593. DOI: https://doi.org/10.5694/mja2.51560

He H, Guttman-Yassky E. JAK inhibitors for atopic dermatitis: An update. Am J Clin Dermatol 2019; 20(2): 181-192. DOI: https://doi.org/10.1007/s40257-018-0413-2

Stevens ML, Zhang Z, Johansson E, Ray S, Jagpal A, Ruff BP, et al. Disease-associated KIF3A variants alter gene methylation and expression, affecting skin barrier and atopic dermatitis risk. Nat Commun 2020; 11(1): 4092. DOI: https://doi.org/10.1038/s41467-020-17895-x

Kern C, Wan J, LeWinn KZ, Ramirez FD, Yong Lee Y, McCulloch CE, et al. Association of atopic dermatitis and mental health outcomes across childhood: A longitudinal cohort study. JAMA Dermatol 2021; 157(10): 1200-1208. DOI: https://doi.org/10.1001/jamadermatol.2021.2657

Fan X, Zang T, Dai J, Wu N, Hope C, Bai J, et al. The associations of maternal and children's gut microbiota with the development of atopic dermatitis in children aged 2 Years. Front Immunol 2022; 13: 1038876. DOI: https://doi.org/10.3389/fimmu.2022.1038876

Han C, Kwon S, Yeom M, Hahm D, Park J, Park H, et al. Exploring the differences in the gut microbiome in atopic dermatitis according to the presence of gastrointestinal symptoms. J Clin Med 2022; 11(13): 3690. DOI: https://doi.org/10.3390/jcm11133690

Ye S, Yan F, Wang H, Mo X, Liu J, Zhang Y, et al. Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population. J Dermatol 2021; 48(2): 158-167. DOI: https://doi.org/10.1111/1346-8138.15530

Tubau C, Puig L. IL-13 antagonists in the treatment of atopic dermatitis. Immunotherapy. 2021; 13(4): 327-344. DOI: https://doi.org/10.2217/imt-2020-0253

Published

2025-11-28

How to Cite

Lisiecka, M. Z. . (2025). Genetic and Immunological Determinants of Atopic Dermatitis: A Systematic Review. International Journal of Child Health and Nutrition, 14(4), 354–375. https://doi.org/10.6000/1929-4247.2025.14.04.4

Issue

Section

General Articles